Cytek Biosciences, Inc. (CTKB)
4.16
+0.17
(+4.26%)
USD |
NASDAQ |
May 28, 14:43
Cytek Biosciences Profit Margin (Quarterly) : -42.75% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Standard BioTools, Inc. | -69.17% |
| Rapid Micro Biosystems, Inc. | -178.4% |
| Henry Schein, Inc. | 3.33% |
| Accendra Health, Inc. | -1.03% |
| Itonis, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -20.50% |
| Return on Assets | -15.54% |
| Return on Invested Capital | -18.78% |
| Gross Profit Margin (Quarterly) | 48.16% |
| Operating Margin (Quarterly) | -41.83% |
| Return on Net Operating Assets | -41.14% |